Internal Medicine, Medical Oncology · Duarte, CA
NPI
1558500397
Since 2009
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1500 Duarte Rd
Duarte, CA, 91010
Phone (626) 256-4673
Groups this clinician bills Medicare through
Medicare paid, 2024
$28K
280 services
Medicare patients, 2024
88
Average age 67
Drug cost, 2024
$977K
284 prescriptions
Company payments, 2025
$81.18
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Molly Diaz was code 99215 (office e&m - established), 201 times for 74 patients. In total Molly Diaz billed 280 services in 10 codes, and Medicare paid $28K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-12-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 201 | 74 | $102.45 | $21K |
| 99215 Office E&M - Established | Office | 42 | 27 | $101.80 | $4,276 |
By year: 2022 $27K for 293 services; 2023 $40K for 413 services; 2024 $28K for 280 services.
Medicare prescription drug claims, 2024
In 2024, the drug Molly Diaz prescribed most often to Medicare patients was Imatinib Mesylate, with 19 prescriptions and refills. In total Molly Diaz wrote 284 Medicare prescriptions that cost $977K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Imatinib Mesylate Generic | 19 | 19 | Under 11 | $4,100 |
| Anastrozole Generic | 18 | 26 | Under 11 | $222 |
| Ogsiveo Nirogacestat Hydrobromide | 17 | 17 | Under 11 | $475K |
| Stivarga Regorafenib | 14 | 14 | Under 11 | $150K |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 13 | 13 | Under 11 | $113 |
| Exemestane Generic | 13 | 13 | Under 11 | $262 |
| Potassium Chloride Generic | 13 | 28 | Under 11 | $507 |
| Dexamethasone Generic | 11 | 12 | Under 11 | $131 |
| Pazopanib Hcl Generic | 11 | 11 | Under 11 | $129K |
Brand drugs: 60 claims; generic drugs: 224 claims; opioid claims: 17.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Molly Diaz $81.18 ($81.18 in general payments such as food, travel and fees) from 3 companies. The largest payer was Deciphera Pharmaceuticals Inc. with $46.96.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.